Orphan Drug Act’s ‘nonprofitability’ loophole needs to be closed
ELISE AMENDOLA/AP
A provision in the Orphan Drug Act that lets a drug company earn orphan status for a drug that will not be profitable needs to be tweaked.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario